je.st
news
InterMune drug may offer big upside to Roche if aimed at liver
2014-08-28 06:40:43| Biotech - Topix.net
Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.
Tags: big
offer
drug
aimed
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||